Last reviewed · How we verify
red yeast rice，RYR
At a glance
| Generic name | red yeast rice，RYR |
|---|---|
| Sponsor | Sichuan Provincial People's Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycystic Ovary Syndrome (EARLY_PHASE1)
- Nutraceuticals and Vascular Remodelling
- Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis (NA)
- Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance (PHASE2)
- Red Yeast Rice and Phytosterols In Statin Intolerance (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- red yeast rice，RYR CI brief — competitive landscape report
- red yeast rice，RYR updates RSS · CI watch RSS
- Sichuan Provincial People's Hospital portfolio CI